Abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid
ICD-10 R83.2 is a billable code used to indicate a diagnosis of abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid.
R83.2 refers to the abnormal levels of drugs, medicaments, and biological substances found in the cerebrospinal fluid (CSF). This condition can indicate various underlying issues, including drug toxicity, therapeutic drug monitoring, or the presence of biological agents such as antibodies or proteins associated with neurological disorders. Symptoms may vary widely depending on the substance involved and the underlying condition, but can include neurological deficits, altered mental status, seizures, or signs of infection. Abnormal findings in CSF can arise from various causes, including drug overdoses, infections, autoimmune diseases, or malignancies. Accurate diagnosis often requires a combination of clinical evaluation, laboratory testing, and imaging studies to determine the cause of the abnormal findings and guide appropriate treatment.
Detailed patient history, including medication use and symptoms, along with lab results.
Patients presenting with neurological symptoms and a history of medication use.
Ensure comprehensive documentation of all medications and biological substances that may affect CSF levels.
Acute care notes, including rapid assessment of neurological status and immediate lab results.
Patients with altered mental status or seizures requiring urgent evaluation of CSF.
Document the urgency of the situation and any immediate interventions performed.
Used to obtain CSF for analysis when abnormal levels are suspected.
Document the indication for the procedure and the findings from CSF analysis.
In neurology, ensure that the rationale for lumbar puncture is clearly documented.
R83.2 can be used for abnormal levels of various drugs, including opioids, antibiotics, and biological agents like antibodies or proteins associated with neurological disorders.
